Welcome to Novo Nordisk in the United States

More than 26 million people in America are living with diabetes - and of those, millions remain undiagnosed and are not receiving treatment. If current projections hold true, more than half of Americans will have diabetes or be prediabetic by 2020 at a cost of trillions of dollars to the U.S. health care system.

We are dedicated to creating value for patients by changing diabetes – changing how it is treated, how it is viewed around the world, and how the future of the disease evolves. While we seek to offer innovative solutions that fit the way people want to live, changing diabetes cannot be achieved through science alone. We have to effect change at every level: in research, in education, in public policy, and in humanitarian and outreach efforts.